- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Ultrasound May Be Appropriate for Women With Focal Noncyclic Breast Pain
Imaging for breast pain is not usually recommended, however, ultrasound may be appropriate for women with focal, noncyclic pain.
Focal noncyclical breast pain is rarely a sign of cancer, however, ultrasound may be an appropriate imaging modality for initial examination, according to an article published in the Journal of the American College of Radiology. A multidisciplinary expert panel annually reviews the American College of Radiology Appropriateness Criteria, evidence-based guidelines for specific clinical conditions, including imaging guidelines for breast cancer screening and diagnosis. The panel reviewed the use of imaging for patients who present with breast pain which, although common, is rarely associated with breast cancer. According to the panel, appropriate workup depends on the nature and focality of the pain, as well as the age of the patient. Imaging evaluation is usually not indicated if the pain is cyclic or nonfocal, while imaging may be appropriate for complaints of focal, noncyclic pain, mainly for reassurance and to identify treatable causes. Ultrasound can be the initial examination used to evaluate women under age 30 with focal, noncyclic breast pain; for women 30 and older, diagnostic mammography, digital breast tomosynthesis, and ultrasound may all serve as appropriate initial examinations. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.
